IRIS - Res&Arch Institutional Research Information System - Research & Archive

PARNETTI, Lucilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.250
AS - Asia 10.736
EU - Europa 9.922
SA - Sud America 2.034
Continente sconosciuto - Info sul continente non disponibili 887
AF - Africa 286
OC - Oceania 29
Totale 39.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.831
SG - Singapore 4.989
IE - Irlanda 1.747
BR - Brasile 1.591
IT - Italia 1.504
CN - Cina 1.457
UA - Ucraina 1.437
RU - Federazione Russa 1.411
HK - Hong Kong 1.351
VN - Vietnam 1.132
DE - Germania 770
SE - Svezia 753
FR - Francia 653
FI - Finlandia 529
KR - Corea 363
GB - Regno Unito 340
BD - Bangladesh 279
IN - India 232
CA - Canada 212
TR - Turchia 163
AR - Argentina 156
IQ - Iraq 126
NL - Olanda 107
AT - Austria 103
PL - Polonia 103
MX - Messico 99
JP - Giappone 91
RO - Romania 87
ZA - Sudafrica 74
UZ - Uzbekistan 72
PK - Pakistan 68
ID - Indonesia 67
CH - Svizzera 65
CO - Colombia 64
VE - Venezuela 59
ES - Italia 57
SA - Arabia Saudita 55
EC - Ecuador 53
CZ - Repubblica Ceca 50
BE - Belgio 48
CL - Cile 37
MA - Marocco 31
EG - Egitto 29
PH - Filippine 28
JO - Giordania 27
PY - Paraguay 26
GR - Grecia 25
DZ - Algeria 24
KE - Kenya 24
TN - Tunisia 24
AE - Emirati Arabi Uniti 23
LB - Libano 23
LT - Lituania 23
MY - Malesia 22
JM - Giamaica 20
NP - Nepal 18
PE - Perù 18
AZ - Azerbaigian 15
AL - Albania 14
CR - Costa Rica 14
DK - Danimarca 14
ET - Etiopia 14
KZ - Kazakistan 14
AU - Australia 13
BO - Bolivia 13
IL - Israele 13
PT - Portogallo 13
UY - Uruguay 13
NI - Nicaragua 12
NZ - Nuova Zelanda 12
OM - Oman 12
EU - Europa 11
BG - Bulgaria 10
HR - Croazia 10
IR - Iran 10
AM - Armenia 9
HN - Honduras 9
KG - Kirghizistan 9
TH - Thailandia 9
PA - Panama 8
TT - Trinidad e Tobago 8
AO - Angola 7
PS - Palestinian Territory 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
MD - Moldavia 6
RS - Serbia 6
SC - Seychelles 6
SY - Repubblica araba siriana 6
BB - Barbados 5
BY - Bielorussia 5
GE - Georgia 5
SI - Slovenia 5
SV - El Salvador 5
BH - Bahrain 4
CG - Congo 4
CI - Costa d'Avorio 4
Totale 38.157
Salva come PNG Salva come JPEG
Città #
Singapore 3.561
Chandler 1.969
Dublin 1.745
San Jose 1.354
Hong Kong 1.335
Ashburn 924
San Mateo 851
Jacksonville 749
Boardman 682
Santa Clara 596
Moscow 521
Dong Ket 479
Altamura 474
Medford 408
Princeton 402
Lauterbourg 396
Perugia 362
Wilmington 358
Seoul 356
Lawrence 355
Beijing 352
Los Angeles 300
Ann Arbor 259
Des Moines 254
New York 229
Munich 228
The Dalles 211
Ho Chi Minh City 209
Andover 184
Hanoi 159
Piscataway 153
São Paulo 132
Helsinki 131
Saint Petersburg 121
Falls Church 94
San Paolo di Civitate 94
Turku 93
Frankfurt am Main 89
Orem 85
Dallas 84
Tokyo 84
Montreal 75
Brooklyn 73
Norwalk 73
Woodbridge 67
Denver 66
Izmir 66
Warsaw 66
Nuremberg 65
Phoenix 65
Chennai 64
Baghdad 58
Chicago 58
Houston 56
Redmond 54
Rome 54
Columbus 53
London 52
Amsterdam 50
Atlanta 48
Stockholm 48
Belo Horizonte 47
Toronto 46
Buffalo 44
Shanghai 43
Tashkent 43
Brussels 42
Poplar 41
Boston 40
Johannesburg 40
Milan 40
Manchester 39
Rio de Janeiro 38
Bucharest 36
Timisoara 35
Council Bluffs 33
San Francisco 33
Mexico City 32
Vienna 32
Curitiba 31
Brasília 29
Da Nang 29
Haiphong 27
Redwood City 27
Campinas 26
Charlotte 26
Naples 25
Seattle 25
Amman 24
Istanbul 24
Caracas 23
Guangzhou 23
Lahore 22
Riyadh 22
Florence 21
Hefei 21
Lappeenranta 21
Den Haag 20
Dhaka 20
Nairobi 20
Totale 23.843
Salva come PNG Salva come JPEG
Nome #
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 284
CSF and blood biomarkers for Parkinson's disease 204
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 197
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 168
A new assay for antiphospholipid antibodies in patient with ischemic stroke 166
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 157
a-D-Mannosidses in patients with familial Alzheimer's Disease 155
Platelet MAO-B activity and vitamin B12 in old age dementias. 149
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 148
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 147
a-D-Mannosidases in patients with Alzheimer's disease 143
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 134
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 134
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 133
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 132
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 132
Hippocampal epileptogenesis in autoimmune encephalitis 132
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 131
Blood pressure and functional aspects of the aging brain. 130
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 128
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 128
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 128
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 127
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 127
A magnetization transfer study of mild and advanced Parkinson's disease. 126
Swalloving dysfunction: neurovascolar- anatomical correlation. 125
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 125
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 125
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 125
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 125
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 125
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 125
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 124
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 124
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 123
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 123
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 123
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 122
Cerebrospinal fluid biomarkers in Parkinson disease. 122
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 121
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 121
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 121
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 121
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 121
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 120
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 120
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 119
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 119
Early admission to stroke unit influences clinical outcome 118
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 118
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 118
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 116
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 116
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 116
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 116
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 116
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 114
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 114
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 114
Is multi-infarct dementia representative of vascular dementias? A retrospective study 113
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 113
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 113
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 112
[Drinking-water and cardiovascular mortality]. 112
Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease. 112
The Italian version of Cognitive Function Instrument (CFI) for tracking changes in healthy elderly: results at 1-year follow-up 112
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 112
Cannabidiol: metabolism and clinical efficacy in epileptic patients 111
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 111
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 111
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 110
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 110
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 110
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 110
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 109
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 109
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 109
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 109
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 109
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 109
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 108
Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice 108
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 107
Brain SPECT in the diagnosis of degenerative dementia. 107
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 107
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. 107
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 107
Amyloid-β: a potential link between epilepsy and cognitive decline 107
Prevalence and risk of progression of preclinical Alzheimer's disease stages: A systematic review and meta-analysis 106
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia 106
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 106
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 106
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 105
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study. 105
[Effects of buflomedil hydrochloride on the rheological properties of the blood in chronic cerebrovascular diseases]. 105
Lysosomal enzyme activities in human brain 105
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 105
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 105
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 104
Totale 12.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.112 0 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20256.102 86 606 234 283 761 351 191 456 1.231 417 995 491
2025/202614.247 1.032 1.005 782 1.935 1.889 1.263 2.360 717 1.440 1.119 445 260
2026/2027891 369 522 0 0 0 0 0 0 0 0 0 0
Totale 39.144